DELTEX MEDICAL GROUP PLC

Remuneration Information • Jun 15, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1071Q

Deltex Medical Group PLC

15 June 2015

Deltex Medical Group plc

Grant of options

15 June 2015 - Deltex Medical Group plc (the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that the Board has approved the issue of share options to Ewan Phillips, Chief Executive.

Employee Share Option Scheme

The Board has approved the issue of share options to Ewan Phillips, Chief Executive, under the Company's 2011 Executive Share Option Scheme ("ESOS") as follows:

Name	Number	Exercise Price £	Exercise period	Total Number of ESOS options held*
Ewan Phillips	1,250,000	0.11	2018 - 2025	4,550,000

*The total number of ESOS options held includes those awarded under the Company's 2001 Executive Share Option Scheme

These options are subject to certain performance conditions being achieved. The Company did not make its normal ESOS awards in either 2013 or 2014. The Company currently intends to make a further ESOS award between publication of its interim results and its year end of 31 December 2015. The exercise price has been set at 11p per share, being the price of the placing and open offer completed in June 2014. This represents a premium of 69.2% over the current share price.

Additional interests

Mr Phillips has a beneficial interest in 2,645,189 ordinary shares in the Company representing 1.23 per cent of the issued ordinary share capital of the Company.

Mr Phillips also holds a total of 2,337,211 options under the Company's Enterprise Management Incentive ("EMI") scheme. Awards under this scheme relate to sacrifices of bonus and salary cash entitlements.

All shares and options relate to ordinary 1p shares.

For further information, please contact:-

Deltex Medical Group plc	01243 774 837 investorinfo@deltexmedical.com
Nigel Keen, Chairman
Ewan Phillips, Chief Executive
Barry Curtis, Company Secretary
Nominated Adviser & Broker
Arden Partners plc	020 7614 5900
Chris Hardie
Joint Broker Zeus Capital Limited Phil Walker Dominic Wilson	020 7533 7727
Financial Public Relations
Newgate	020 7653 9850
Tim Thompson
Robyn McConnachie Ed Treadwell

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLFFVFRFISLIE